BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9844019)

  • 1. Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells.
    Smit MJ; Verzijl D; Iyengar R
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):15084-9. PubMed ID: 9844019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
    Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
    Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6.
    Pieroni JP; Harry A; Chen J; Jacobowitz O; Magnusson RP; Iyengar R
    J Biol Chem; 1995 Sep; 270(36):21368-73. PubMed ID: 7673172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of adenylyl cyclase isoforms mediating parathyroid hormone- and calcitonin-stimulated cyclic AMP accumulation in distal tubule cells.
    Kittikulsuth W; Friedman PA; van Hoek A; Gao Y; Kohan DE
    BMC Nephrol; 2017 Sep; 18(1):292. PubMed ID: 28882112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming G protein-coupled receptors transduce potent mitogenic signals in NIH 3T3 cells independent on cAMP inhibition or conventional protein kinase C.
    Stephens EV; Kalinec G; Brann MR; Gutkind JS
    Oncogene; 1993 Jan; 8(1):19-26. PubMed ID: 8380916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus.
    Yokoyama U; Minamisawa S; Katayama A; Tang T; Suzuki S; Iwatsubo K; Iwasaki S; Kurotani R; Okumura S; Sato M; Yokota S; Hammond HK; Ishikawa Y
    Circ Res; 2010 Jun; 106(12):1882-92. PubMed ID: 20431059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PKCeta in NIH-3T3 cells promotes production of the pro-inflammatory cytokine interleukin-6.
    Fima E; Shahaf G; Hershko T; Apte RN; Livneh E
    Eur Cytokine Netw; 1999 Dec; 10(4):491-500. PubMed ID: 10586115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenylyl cyclase 3 mediates prostaglandin E(2)-induced growth inhibition in arterial smooth muscle cells.
    Wong ST; Baker LP; Trinh K; Hetman M; Suzuki LA; Storm DR; Bornfeldt KE
    J Biol Chem; 2001 Sep; 276(36):34206-12. PubMed ID: 11432866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative phosphoproteomic analysis reveals unique cAMP signaling pools emanating from AC2 and AC6 in human airway smooth muscle cells.
    Cattani-Cavalieri I; Li Y; Margolis J; Bogard A; Roosan MR; Ostrom RS
    Front Physiol; 2023; 14():1149063. PubMed ID: 36926196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation.
    Chen Y; Harry A; Li J; Smit MJ; Bai X; Magnusson R; Pieroni JP; Weng G; Iyengar R
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14100-4. PubMed ID: 9391159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bronchial smooth muscle cells express adenylyl cyclase isoforms 2, 4, and 6 in distinct membrane microdomains.
    Bogard AS; Xu C; Ostrom RS
    J Pharmacol Exp Ther; 2011 Apr; 337(1):209-17. PubMed ID: 21228062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
    Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor dysfunction in type 5 adenylyl cyclase-null mice.
    Iwamoto T; Okumura S; Iwatsubo K; Kawabe J; Ohtsu K; Sakai I; Hashimoto Y; Izumitani A; Sango K; Ajiki K; Toya Y; Umemura S; Goshima Y; Arai N; Vatner SF; Ishikawa Y
    J Biol Chem; 2003 May; 278(19):16936-40. PubMed ID: 12665504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.
    Conley JM; Brand CS; Bogard AS; Pratt EP; Xu R; Hockerman GH; Ostrom RS; Dessauer CW; Watts VJ
    J Pharmacol Exp Ther; 2013 Nov; 347(2):276-87. PubMed ID: 24008337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
    Benjamin CW; Tarpley WG; Gorman RR
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):546-50. PubMed ID: 3099298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-induced Ras protein 1 negatively regulates protein kinase C delta: implications for adenylyl cyclase 2 signaling.
    Nguyen CH; Watts VJ
    Mol Pharmacol; 2006 May; 69(5):1763-71. PubMed ID: 16489124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.